• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Cost-effectiveness of elderly health examination program: the example of hypertension screening.老年健康检查项目的成本效益:以高血压筛查为例。
Kaohsiung J Med Sci. 2007 Jan;23(1):17-24. doi: 10.1016/S1607-551X(09)70369-9.
2
The Cost-Effectiveness of Low-Cost Essential Antihypertensive Medicines for Hypertension Control in China: A Modelling Study.中国低成本基本降压药物控制高血压的成本效益:一项建模研究
PLoS Med. 2015 Aug 4;12(8):e1001860. doi: 10.1371/journal.pmed.1001860. eCollection 2015 Aug.
3
4
Changes in blood pressure among users of lay health worker or volunteer operated community-based blood pressure programs over time: a systematic review protocol.随着时间推移,由非专业卫生工作者或志愿者运营的社区血压项目使用者的血压变化:一项系统评价方案
JBI Database System Rev Implement Rep. 2015 Oct;13(10):30-40. doi: 10.11124/jbisrir-2015-1927.
5
Applicability and cost-effectiveness of the Systolic Blood Pressure Intervention Trial (SPRINT) in the Chinese population: A cost-effectiveness modeling study.在中国人群中开展收缩压干预试验(SPRINT)的适用性和成本效益:一项成本效益建模研究。
PLoS Med. 2021 Mar 4;18(3):e1003515. doi: 10.1371/journal.pmed.1003515. eCollection 2021 Mar.
6
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
7
Cost-effectiveness of the lower treatment goal (of JNC VI) for diabetic hypertensive patients. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.糖尿病高血压患者(美国国家联合委员会第六次报告所提出)较低治疗目标的成本效益。国家高血压预防、检测、评估与治疗联合委员会。
Arch Intern Med. 2000 May 8;160(9):1277-83. doi: 10.1001/archinte.160.9.1277.
8
The cost-effectiveness of pharmacist-physician collaborative care models vs usual care on time in target systolic blood pressure range in patients with hypertension: a payer perspective.药师-医师协作护理模式与常规护理对高血压患者目标收缩压达标时间的成本效果分析:支付者视角。
J Manag Care Spec Pharm. 2021 Dec;27(12):1680-1690. doi: 10.18553/jmcp.2021.27.12.1680.
9
Primary Technology-Enhanced Care for Hypertension Scaling Program: Trial-Based Economic Evaluation Examining Effectiveness and Cost-Effectiveness Using Real-World Data in Singapore.高血压初级技术强化护理扩展项目:在新加坡使用真实世界数据进行基于试验的经济评估,考察有效性和成本效益。
J Med Internet Res. 2025 Apr 15;27:e59275. doi: 10.2196/59275.
10
Cost-Effectiveness Analysis of Screening for and Managing Identified Hypertension for Cardiovascular Disease Prevention in Vietnam.越南心血管疾病预防中高血压筛查与管理的成本效益分析
PLoS One. 2016 May 18;11(5):e0155699. doi: 10.1371/journal.pone.0155699. eCollection 2016.

引用本文的文献

1
Cost-Effectiveness Analysis of Hypertension Screening in the Korea National Health Screening Program.韩国国民健康筛查计划中高血压筛查的成本效益分析。
Korean Circ J. 2021 Jul;51(7):610-622. doi: 10.4070/kcj.2021.0051. Epub 2021 May 14.
2
Cost-effectiveness of nitrendipine and hydrochlorothiazide or metoprolol to treat hypertension in rural community health centers in China.在中国农村社区卫生中心使用硝苯地平与氢氯噻嗪或美托洛尔治疗高血压的成本效益
J Hypertens. 2017 Apr;35(4):886-892. doi: 10.1097/HJH.0000000000001209.
3
Cost-Effectiveness Analysis of Screening for and Managing Identified Hypertension for Cardiovascular Disease Prevention in Vietnam.越南心血管疾病预防中高血压筛查与管理的成本效益分析
PLoS One. 2016 May 18;11(5):e0155699. doi: 10.1371/journal.pone.0155699. eCollection 2016.
4
Relationship between obesity, metabolic syndrome, and nonalcoholic fatty liver disease in the elderly agricultural and fishing population of Taiwan.台湾老年农民和渔民群体中肥胖、代谢综合征与非酒精性脂肪性肝病的关系。
Clin Interv Aging. 2014 Mar 27;9:501-8. doi: 10.2147/CIA.S59538. eCollection 2014.
5
Health examination utilization in the visually disabled population in Taiwan: a nationwide population-based study.台湾视障人群健康检查利用情况:一项基于全国人口的研究。
BMC Health Serv Res. 2013 Dec 5;13:509. doi: 10.1186/1472-6963-13-509.
6
Cost-effectiveness of a hypertension control intervention in three community health centers in China.中国三个社区卫生中心高血压控制干预措施的成本效益
J Prim Care Community Health. 2013 Jul 1;4(3):195-201. doi: 10.1177/2150131912470459. Epub 2013 Jan 7.

本文引用的文献

1
Prevalence and determinants of prehypertension status in the Taiwanese general population.台湾一般人群中高血压前期状态的患病率及其决定因素。
J Hypertens. 2005 Jul;23(7):1355-60. doi: 10.1097/01.hjh.0000173517.68234.c3.
2
Organization and delivery of long-term care in Taiwan.台湾长期照护的组织与提供
J Aging Soc Policy. 2001;13(2-3):217-32. doi: 10.1300/j031v13n02_15.
3
Incidence and predictors of isolated systolic hypertension and isolated diastolic hypertension in Taiwan.台湾单纯收缩期高血压和单纯舒张期高血压的发病率及预测因素
J Formos Med Assoc. 2001 Oct;100(10):668-75.
4
Prevalence, awareness, treatment and control of hypertension in Taiwan: results of Nutrition and Health Survey in Taiwan (NAHSIT) 1993-1996.
J Hum Hypertens. 2001 Nov;15(11):793-8. doi: 10.1038/sj.jhh.1001268.
5
Hypertension in elderly persons: its prevalence and associated cardiovascular risk factors in Tainan City, southern Taiwan.
J Gerontol A Biol Sci Med Sci. 2000 Aug;55(8):M463-8. doi: 10.1093/gerona/55.8.m463.
6
A long-term follow-up of stroke patients.中风患者的长期随访
Stroke. 1997 Mar;28(3):507-12. doi: 10.1161/01.str.28.3.507.
7
Incidence of hypertension and non-insulin dependent diabetes mellitus and associated risk factors in a rapidly developing Caribbean community: the St James survey, Trinidad.特立尼达岛圣詹姆斯地区一项快速发展的加勒比社区中高血压和非胰岛素依赖型糖尿病的发病率及相关危险因素调查
J Epidemiol Community Health. 1996 Oct;50(5):497-504. doi: 10.1136/jech.50.5.497.
8
The cost-effectiveness of treating hypertension in elderly people--an analysis of the Swedish Trial in Old Patients with Hypertension (STOP Hypertension).老年人高血压治疗的成本效益——瑞典老年高血压患者试验(STOP高血压)分析
J Intern Med. 1993 Sep;234(3):317-23. doi: 10.1111/j.1365-2796.1993.tb00749.x.
9
Cost-benefit of treating hypertension.
J Hypertens Suppl. 1994 Dec;12(10):S65-70.
10
Stroke in the People's Republic of China. II. Meta-analysis of hypertension and risk of stroke.
Stroke. 1995 Dec;26(12):2228-32.

老年健康检查项目的成本效益:以高血压筛查为例。

Cost-effectiveness of elderly health examination program: the example of hypertension screening.

作者信息

Deng Bing-Hwa, Liu Hong-Wen, Pan Pi-Chen, Mau Lih-Wen, Chiu Herng-Chia

机构信息

Management Office, Kaohsiung Municipal Hsiao-Kang Hospital, and Department of Family Medicine, Kaohsiung Medical University Hospital, Taiwan.

出版信息

Kaohsiung J Med Sci. 2007 Jan;23(1):17-24. doi: 10.1016/S1607-551X(09)70369-9.

DOI:10.1016/S1607-551X(09)70369-9
PMID:17282981
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11918239/
Abstract

The National Health Insurance (NHI) and social welfare agencies have implemented the Elderly Health Examination Program (EHEP) for years. No study has ever attempted to evaluate whether this program is cost-effective. The purposes of this study were, firstly, to understand the prevalence and incidence rates of hypertension and, secondly, to estimate the cost and effectiveness of the EHEP, focusing on hypertension screening. The data sources were: (1) hypertension and clinical information derived from the 1996 and 1997 EHEP, which was used to generate prevalence and incidence rates of hypertension; and (2) claim data of the NHI that included treatment costs of stroke patients (in- and outpatients). Hypothetical models were used to evaluate the cost-effectiveness of the hypertension screening program in various conditions. Sensitivity analysis was also employed to evaluate the effect of each estimation indicator on the cost and effectiveness of the hypertension screening program. A total of 28.3% of the elderly population in Kaohsiung (25,174 of 88,812) participated in the 1996 EHEP; 14,915 of them participated in the following 1997 EHEP, with a retention rate of 59.3%. Criteria from the Sixth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI) (systolic blood pressure/diastolic blood pressure>or=160/95 mmHg or taking antihypertensive drugs) were used; we found that prevalence and incidence rates of hypertension were 24.6% and 6.6%, respectively. Hypertension rates are increasing in the aging process as shown in both prevalence and incidence models. In comparison with non-participants, the prevalence model indicates that each hypertension patient who had attended the EHEP not only saved NT$34,570-34,890 in medical and associated costs, but also increased their lifespan by 128 days. The present findings suggest that the EHEP is a cost-effective program with health and social welfare policy implications. With the relatively low participation rate of the EHEP, health and social agencies need to put more effort into the promotion of this free health examination program to attract potential participants. In doing so, the population at risk for hypertension would be identified for early treatment, and the probability of having stroke could be decreased. Consequently, health care expenditures for treatment and caregiving of stroke patients would be minimized. Finally, it should be noted that the sensitivity and values of selected parameters can modify the results of cost-effectiveness analysis. Interpretations of the effects of prevention services on costs and effectiveness need to be treated with caution.

摘要

国民健康保险(NHI)和社会福利机构多年来一直在实施老年健康检查计划(EHEP)。从未有研究试图评估该计划是否具有成本效益。本研究的目的,一是了解高血压的患病率和发病率,二是评估EHEP的成本和效果,重点是高血压筛查。数据来源为:(1)1996年和1997年EHEP得出的高血压及临床信息,用于得出高血压的患病率和发病率;(2)NHI的理赔数据,包括中风患者(门诊和住院)的治疗费用。使用假设模型评估高血压筛查计划在各种情况下的成本效益。还采用敏感性分析来评估每个估计指标对高血压筛查计划成本和效果的影响。高雄市共有28.3%的老年人口(88,812人中的25,174人)参加了1996年的EHEP;其中14,915人参加了随后的1997年EHEP,保留率为59.3%。采用美国国家高血压检测、评估与治疗联合委员会第六次报告(JNC VI)的标准(收缩压/舒张压>或=160/95 mmHg或正在服用降压药);我们发现高血压的患病率和发病率分别为24.6%和6.6%。患病率和发病率模型均显示,高血压发病率在老龄化过程中呈上升趋势。与未参与者相比,患病率模型表明,每位参加EHEP的高血压患者不仅节省了34,570 - 34,890新台币的医疗及相关费用,还延长了128天的寿命。目前的研究结果表明,EHEP是一个具有成本效益的计划,对健康和社会福利政策具有启示意义。鉴于EHEP的参与率相对较低,卫生和社会机构需要更加努力地推广这个免费健康检查计划,以吸引潜在参与者。这样做可以识别出高血压高危人群以便早期治疗,并降低中风的发生概率。因此,中风患者的治疗和护理医疗费用将降至最低。最后需要指出的是,所选参数的敏感性和数值会改变成本效益分析的结果。对预防服务对成本和效果影响的解读需要谨慎对待。